NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical ...
Serving children, adolescents, and adults, EM Psych offers comprehensive evaluations, therapy, medication management, and ...
“Trial and error” remains the basis for the care of people who have recently been diagnosed with psychosis, and “poor outcomes are common,” say a team of researchers at the University of California, ...
For people living with schizophrenia who may find daily disease management overwhelming due to fragmented support and resources, Home Ground(TM) Schizophrenia Community is a centralized destination ...
Popular trauma-focused talking therapies can help people challenge false beliefs and distorted thinking patterns but do ...
A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of ...
The U.S. health care system is often described as strained or overwhelmed. From where I am sitting, it is broken. The ...
Background: Patients suffering from psychotic disorders have an increased risk of comorbid somatic diseases such as cardiovascular disorders and diabetes mellitus. Doctor-related factors, such as ...
In 1969, a controversial experiment used amphetamines to induce psychosis in healthy volunteers—changing our understanding of ...
Add Yahoo as a preferred source to see more of our stories on Google. A former patient of an Idaho program that sought to keep people with severe psychosis on their medication has died, providers said ...
Psychosis patients in Northern Ireland are being failed because of a lack of official data on how many people are suffering with the mental health condition. That is according to Margaret Gibney, a ...